Half-Life
Half-Life — The time required for the concentration of a compound to decrease by 50%, a critical parameter in pharmacokinetic research and experimental design.
What Is Half-Life?
Half-life (t½) is the time required for the concentration or biological activity of a compound to decrease by 50%. In peptide research, this metric determines dosing frequency, experimental timing, and formulation strategy. Most unmodified linear peptides have plasma half-lives measured in minutes, driven by rapid proteolytic degradation and renal clearance.
Types of Half-Life
- Plasma half-life: Time for plasma concentration to drop by 50%. Governed by proteolysis, renal filtration, and hepatic metabolism
- Biological half-life: Time for pharmacological effect to decrease by 50%. May differ significantly from plasma half-life if the peptide accumulates in target tissues
- Terminal half-life: The slowest elimination phase in multi-compartment models, reflecting redistribution from tissue depots
Peptide Half-Life Comparison
- GLP-1: ~2 minutes (rapidly cleaved by DPP-IV)
- Oxytocin: ~3-5 minutes
- Ipamorelin: ~2 hours
- CJC-1295 DAC: ~8 days (albumin binding extends duration)
Half-Life Extension Strategies
PEGylation, albumin binding, Fc fusion, D-amino acid substitution, and cyclization are proven approaches for extending peptide half-life from minutes to hours or days.
Frequently Asked Questions
What is Half-Life?
The time required for the concentration of a compound to decrease by 50%, a critical parameter in pharmacokinetic research and experimental design.
Why is Half-Life important in peptide research?
Half-Life is a fundamental concept in pharmacology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.